Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 20, 16:00
3.05
-0.03
(-0.97%)
After-Hours: 20:00
Revance Therapeutics Total Liabilities (Quarterly): 624.59M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 201.94M |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Ligand Pharmaceuticals Inc | 113.69M |
| MEI Pharma Inc | 2.872M |
| Cellectar Biosciences Inc | 22.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 461.56M |
| Shareholders Equity (Quarterly) | -163.03M |
| Debt to Equity Ratio | -2.645 |
| Current Ratio | 4.119 |
| Net Debt Paydown Yield | -1.87% |